Andrew Shaughnessy

Fostering Innovation And Protecting Investments: Patent Law's Double-Edged Sword And Environmental Technologies

The Latest On Canada's Patented Medicine Prices Review Board: Not The "All Medicine Prices Review Board"

Is It Real Or Is It Memorex? Does AI Threaten IP?

Ask An IP Litigator: Do I Have A Great Patent? (Video)

Federal Court Of Appeal Underscores The Importance Of Patent Terms In Invalidating Claims To "Physiologically Acceptable" Salts

Federal Court Of Appeal Limits Scope Of Prohibition Against Patenting Methods Of Medical Treatment

Patent On Differin XP Gives PMPRB Pricing Jurisdiction Over Differin: Federal Court

Federal Court Of Appeal "Skinny Label" Case Highlights The Potential Power Of The Patentee

Interim Pricing Guidance Adopted As Canada's PMPRB Continues To Move Towards New Guidelines

FCA: PMPRB11 Stands For Patented Medicines